Avantor (AVTR) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $0.22
- Estimate
- $0.21
- Surprise
- +5.6%
- Revenue (period 2026-09-30)
- $1.70B
- Score today
- 5.7/10
Revenue source: xbrl.
How the report landed
Avantor (AVTR) beat the $0.21 estimate with adjusted EPS of $0.22 — a clear 5.6% upside surprise.
Coverage in the report window
- Incyte To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Friday — benzinga, 2026-10-30
- Analysts Update Ratings and Price Targets for Avantor — fiscal.ai, 2026-10-29
- RBC Capital Maintains Sector Perform on Avantor, Raises Price Target to $17 — benzinga, 2026-10-29
Where TrendMatrix's rating stands now
TrendMatrix currently rates AVTR Hold at 5.7/10; no pre/post engine snapshot brackets this report.
3 of the last 4 quarters beat the estimate; this quarter's +5.6% surprise compares with a +6.6% four-quarter average. Next scheduled report: 2027-02-10.
What supports the rating
- Strong earnings beat streak (3/4)
What argues against it
- Concentration risk — Supplier: sole-sourced raw materials
- Analyst target reached - limited upside remaining
- Negative momentum
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $15.34
- Stop
- $14.62
The stock trades at 30.4× trailing but 17.1× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-11-18 — shown for context, not personalized investment advice.
AVTR at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Instruments & Supplies
- Market cap
- $10.29B
- P/E (fwd)
- 17.1
- P/E (ttm)
- 30.4
- 52-week range
- $7.26–$17.45
- Off 52-week high
- 12.1%
- RSI (14)
- 31
- Volume vs avg
- 0.41×
- Score today
- 5.7/10